MICOT PHARMA-B's Hong Kong IPO Sees Massive Oversubscription, Final Price Set at HK$18.2

Stock News
Jun 23

The share allocation results for MICOT PHARMA-B (02335) have been announced.

The company's global offering consists of approximately 58.0544 million H shares. The Hong Kong public offering portion accounts for 10% of the total, with the international offering making up the remaining 90%.

The final offer price has been set at HK$18.2 per share. The net proceeds from the global offering are expected to be approximately HK$989 million.

Each board lot comprises 200 shares. The H shares are scheduled to commence trading on the Stock Exchange at 9:00 a.m. on Wednesday, June 24, 2026.

The Hong Kong public offering was oversubscribed by approximately 1,181.46 times. The international offering was oversubscribed by about 2.52 times.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10